Author:
Sagay Atiene S.,Hsieh Szu-Chia,Dai Yu-Ching,Chang Charlotte Ajeong,Ogwuche Jerry,Ige Olukemi O.,Kahansim Makshwar L.,Chaplin Beth,Imade Godwin,Elujoba Michael,Paul Michael,Hamel Donald J.,Furuya Hideki,Khoury Ricardo,Boaventura Viviane Sampaio,de Moraes Laíse,Kanki Phyllis J.,Wang Wei-Kung
Abstract
ABSTRACTChikungunya virus (CHIKV) has become a global public health concern since the reemergence of the Indian Ocean lineage and expansion of the Asian genotype. CHIKV infection causes acute febrile illness, rash, and arthralgia and during pregnancy may affect both mothers and infants.The mother-to-child transmission (MTCT) of CHIKV in Africa remains understudied. We screened 1006 pregnant women at two clinics in Nigeria between 2019 and 2022 and investigated the prevalence and MTCT of CHIKV. Of the 1006, 119 tested positive for CHIKV IgM, of which 36 underwent detailed laboratory tests. While none of the IgM reactive samples were RT-PCR positive, 14 symptomatic pregnant women were confirmed by CHIKV neutralization test. Twelve babies were followed with 8 normal and 4 abnormal outcomes, including stillbirth, cleft lip/palate with microcephaly, preterm delivery, polydactyly with sepsis and jaundice. CHIKV IgM testing identified 3 antepartum transmissions, further studies will determine its impact in antepartum infection.
Publisher
Cold Spring Harbor Laboratory
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献